The lipid-lowering potential of flavonoid-rich portion of Combretum micranthum (CM) on a high-fat diet (HFD) induced albino rats was evaluated. Hyperlipidaemic rats were divided into six groups. Group I (Normal control), group II (HFD-fed only), while group III, IV and V received aqueous methanol (80%) leaf extract of CM at varied doses of 100, 200 and 400 mg/kg, respectively, while group VI were given the standard drug-Atorvastatin (4 mg/kg) for two weeks. Total Cholesterol (TC), Triacylglycerol (TAG), High Density Lipoproteins (HDL-C), Creatine Kinase (CK), and Lactate Dehydrogenase (LDH) were assayed spectrophotometrically and Atherogenic Index (AI) calculated using standard formula. GC-MS revealed 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one, 5-oxycatechol and 1,2,3-benzene-triol to be the principal compounds. Significant reduction in TC, TAG, LDL-C, AI, CK, LDH and increased in HDL-C were observed compared to hyperlipidemic control (p<0.05) hence CM could be used in the management of risk of CVDs.
No takes yet. Share an insight, caveat, or question.
Babandi et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: